about
Management of carotid stenosis in women: consensus documentBenefit of clopidogrel over aspirin is amplified in patients with a history of ischemic eventsAmplified benefit of clopidogrel versus aspirin in patients with diabetes mellitusThrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials ArchiveSelection of possible responders to thrombolytic therapy in acute ischemic stroke.Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials.Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data.Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial.Comparison of susceptibility weighted imaging and TOF-angiography for the detection of Thrombi in acute stroke.Stenting for carotid artery stenosis.Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study.To stent or not to stent: stent-protected percutaneous angioplasty versus endarterectomy post hoc analyses.Why calls for more routine carotid stenting are currently inappropriate: an international, multispecialty, expert review and position statement.The Impact of Conscious Sedation versus General Anesthesia for Stroke Thrombectomy on the Predictive Value of Collateral Status: A Post Hoc Analysis of the SIESTA Trial.Minor Stroke Syndromes in Large-Vessel Occlusions: Mechanical Thrombectomy or Thrombolysis Only?Mechanical Thrombectomy in Patients with Acute Ischemic Stroke and Lower NIHSS Scores: Recanalization Rates, Periprocedural Complications, and Clinical Outcome.IV thrombolysis and renal function.Endovascular Stroke Treatment of Nonagenarians.Improved prediction of poor outcome after thrombolysis using conservative definitions of symptomatic hemorrhage.Evaluation of the obesity genes FTO and MC4R and the type 2 diabetes mellitus gene TCF7L2 for contribution to stroke risk: The Mannheim-Heidelberg Stroke Study.Observation of indirect neorevascularization after leptomeningeal biopsy in a 34-year-old woman with moyamoya syndrome--should burr holes be considered as an alternative revascularization technique in younger adults with moyamoya?Mechanical Thrombectomy of Distal Occlusions in the Anterior Cerebral Artery: Recanalization Rates, Periprocedural Complications, and Clinical Outcome.Hashimoto encephalopathy: rare cause of stroke in young patient.Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset.Redo surgery or carotid stenting for restenosis after carotid endarterectomy: results of two different treatment strategies.Pharmacogenetic testing for guiding de novo phenprocoumon therapy in stroke patients.Impact of statin use and lipid profile on symptomatic intracerebral haemorrhage, outcome and mortality after intravenous thrombolysis in acute stroke.Relationship between onset-to-door time and door-to-thrombolysis time: a pooled analysis of 10 dedicated stroke centers.Differences in complication rates among the centres in the SPACE study.Late outcome after surgical management of carotid body tumors from a 20-year single-center experience.Ultra-early intravenous stroke thrombolysis: do all patients benefit similarly?Oral anticoagulants--a frequent challenge for the emergency management of acute ischemic stroke.Postoperative neurological deficit after carotid endarterectomy: a mid-term outcome analysis.Glycosylated hemoglobin A1 predicts risk for symptomatic hemorrhage after thrombolysis for acute stroke.Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations.Therapy of acute basilar artery occlusion: intraarterial thrombolysis alone vs bridging therapy.Fast-track intubation for accelerated interventional stroke treatment.MRI in patients with acute basilar artery occlusion - DWI lesion scoring is an independent predictor of outcome.Herpes simplex virus encephalitis despite normal cell count in the cerebrospinal fluid.Frequency of increased blood pressure levels during systemic thrombolysis and risk of intracerebral hemorrhage.
P50
Q26852050-08003B49-5C3E-4108-BD7F-06D4E9271EC4Q28166894-583A1168-6A25-4AE6-84B6-4C16B0C89BF8Q28193753-065D73EF-1BEC-42E6-9F4E-3133B5799589Q28748178-CF83BF79-F100-4CFA-819E-0E6F61BE2D8DQ30568984-01CEF845-DCAB-4900-B32F-A5FA4E71FAC4Q31030765-5C5E4E1E-6609-4931-8C0C-C008F77C1216Q33690251-B35A2ADD-A0AA-4823-B091-BFB574FA83CDQ34425337-1A9AE655-F4DF-401E-8139-63153C5016F6Q34744120-D7460216-0869-469D-903E-2AB248BC5DDBQ36780748-9077019A-7C67-433D-90E3-4485E709C74DQ37314662-48A124F9-F231-438E-A7B5-12CE9C2A3A2EQ37373247-C8FEE461-F176-449D-9C05-8918FDDBAC85Q38091405-D96059F1-1ECA-4525-8710-33A533C4377FQ38735452-2CC2E5EF-5B0A-48F1-B08B-3D2B3C0B600CQ38837575-04958031-0530-42F1-82C4-0EECE902BF23Q38846456-54A11932-2186-41DF-BA60-03FBEFF950D4Q39020463-AAFD5B05-09AD-44F1-AD6A-629B0CFDA8EAQ39241871-1897A008-13C0-4933-8362-2AEA56DAAC78Q39697626-6C2FB1E1-73AC-45E2-A7C0-2A37D61309EBQ39707173-8A331C69-AA35-4F81-8787-DD3CBC183E1EQ40012593-30592AA3-9A6F-4406-A180-361F5F83EABEQ40350754-F77A266A-28A8-4CD9-BC25-3254E4D26934Q40374414-7E513F55-A341-4E7B-831B-FDD719E76F16Q43199823-A19919EB-2DE9-4009-8110-EECD6193C394Q43277517-2CBE157D-8202-4959-AB45-F12C57149FCDQ43279457-B517F4DB-08CD-465C-8D67-18040917303EQ43483709-9E8F8129-61E6-4500-B29E-79C512348E3AQ43553554-7B0799D2-E29B-4DAD-8716-99623874B2D4Q43658185-3932B5B6-CBCA-46C4-A2F3-FF33A1DB71A3Q43804654-78A3920E-8796-4CEE-95EE-3D12E0064371Q43888925-5C469E53-2DE2-4E8A-8CE4-E2DACF6740F8Q44115938-0FE9128D-4A21-47CA-B69C-04876B4B4CAEQ44228087-177EAF8A-C83B-490F-9CA8-72ED987D473AQ44295471-EF01B7E9-F4E3-4ADC-A507-AE33C94A569DQ44493585-5CBFB569-1C43-4A3D-AB2E-6360F936C171Q44692570-D5087790-ADDE-4BD1-83ED-68BDF7226981Q44707981-AC1192C1-A336-458D-9476-9F20BAFD2C3EQ45057078-7B8B62A4-9359-4780-B354-254CCD07D0C5Q45361892-B47FCA1F-B5DE-412F-8DFE-71AB46F21903Q46335226-4BADF3EE-D3C0-42B2-89A9-6E238D425531
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Peter A Ringleb
@ast
Peter A Ringleb
@en
Peter A Ringleb
@es
Peter A Ringleb
@nl
Peter A Ringleb
@sl
type
label
Peter A Ringleb
@ast
Peter A Ringleb
@en
Peter A Ringleb
@es
Peter A Ringleb
@nl
Peter A Ringleb
@sl
altLabel
Peter Ringleb
@en
prefLabel
Peter A Ringleb
@ast
Peter A Ringleb
@en
Peter A Ringleb
@es
Peter A Ringleb
@nl
Peter A Ringleb
@sl
P214
P106
P21
P214
P31
P496
0000-0002-5473-8671
P735
P7859
viaf-315216896